These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 23158988

  • 1. [Preliminary analysis of differentially expressed proteins of clear-cell renal cell carcinoma by comparative proteomic technologies].
    Yang J, Li X, Tian MJ, Wang LN, Cheng TT, Chen W.
    Zhonghua Zhong Liu Za Zhi; 2012 Aug; 34(8):571-6. PubMed ID: 23158988
    [Abstract] [Full Text] [Related]

  • 2. Proteomic identification of angiomotin by ProteomeLab PF-2D and correlation with clinical outcome in human clear cell renal cell carcinoma.
    Yang J, Liu P, Tian M, Li Y, Chen W, Li X.
    Int J Oncol; 2013 Jun; 42(6):2078-86. PubMed ID: 23588948
    [Abstract] [Full Text] [Related]

  • 3. [Effects of SIPL1 screened by suppression subtractive hybridization (SSH) on biological function and drug resistance of renal cell carcinoma cells].
    Li CY, Yao AM, Chang XN, Guo YH, Xu R.
    Zhonghua Zhong Liu Za Zhi; 2013 Dec; 35(12):897-903. PubMed ID: 24506958
    [Abstract] [Full Text] [Related]

  • 4. [Expression of oxidative stress proteins in the clear-cell renal cell carcinoma].
    Tian MJ, Li YY, Luo CQ, Lv ML, Yang J.
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Aug; 28(8):851-5. PubMed ID: 22863595
    [Abstract] [Full Text] [Related]

  • 5. Proteomic analysis reveals differentially secreted proteins in the urine from patients with clear cell renal cell carcinoma.
    Sandim V, Pereira Dde A, Kalume DE, Oliveira-Carvalho AL, Ornellas AA, Soares MR, Alves G, Zingali RB.
    Urol Oncol; 2016 Jan; 34(1):5.e11-25. PubMed ID: 26420021
    [Abstract] [Full Text] [Related]

  • 6. High-level S100A6 promotes metastasis and predicts the outcome of T1-T2 stage in clear cell renal cell carcinoma.
    Lyu X, Li H, Ma X, Li X, Gao Y, Ni D, Shen D, Gu L, Wang B, Zhang Y, Zhang X.
    Cell Biochem Biophys; 2015 Jan; 71(1):279-90. PubMed ID: 25120023
    [Abstract] [Full Text] [Related]

  • 7. Down-regulation of CD74 inhibits growth and invasion in clear cell renal cell carcinoma through HIF-1α pathway.
    Ji SQ, Su XL, Cheng WL, Zhang HJ, Zhao YQ, Han ZX.
    Urol Oncol; 2014 Feb; 32(2):153-61. PubMed ID: 23273913
    [Abstract] [Full Text] [Related]

  • 8. Overexpression of FABP7 promotes cell growth and predicts poor prognosis of clear cell renal cell carcinoma.
    Zhou J, Deng Z, Chen Y, Gao Y, Wu D, Zhu G, Li L, Song W, Wang X, Wu K, He D.
    Urol Oncol; 2015 Mar; 33(3):113.e9-17. PubMed ID: 25192834
    [Abstract] [Full Text] [Related]

  • 9. Histology-guided proteomic analysis to investigate the molecular profiles of clear cell Renal Cell Carcinoma grades.
    Stella M, Chinello C, Cazzaniga A, Smith A, Galli M, Piga I, Grasso A, Grasso M, Del Puppo M, Varallo M, Bovo G, Magni F.
    J Proteomics; 2019 Jan 16; 191():38-47. PubMed ID: 29698802
    [Abstract] [Full Text] [Related]

  • 10. Identification of cyclophilin A as a potential prognostic factor for clear-cell renal cell carcinoma by comparative proteomic analysis.
    Yang J, Li A, Yang Y, Li X.
    Cancer Biol Ther; 2011 Mar 01; 11(5):535-46. PubMed ID: 21368578
    [Abstract] [Full Text] [Related]

  • 11. Dicer is down-regulated in clear cell renal cell carcinoma and in vitro Dicer knockdown enhances malignant phenotype transformation.
    Ma X, Fan Y, Gao Y, Zhang Y, Huang Q, Ai Q, Ni D, Chen W, Zhang P, Song E, Wang B, Shi T, Zheng T, Zhang X.
    Urol Oncol; 2014 Jan 01; 32(1):46.e9-17. PubMed ID: 24094887
    [Abstract] [Full Text] [Related]

  • 12. MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor PDCD4 and promotes cell transformation, proliferation, and metastasis in renal cell carcinoma.
    Li X, Xin S, He Z, Che X, Wang J, Xiao X, Chen J, Song X.
    Cell Physiol Biochem; 2014 Jan 01; 33(6):1631-42. PubMed ID: 24902663
    [Abstract] [Full Text] [Related]

  • 13. Overexpression of placenta specific 8 is associated with malignant progression and poor prognosis of clear cell renal cell carcinoma.
    Shi L, Xiao L, Heng B, Mo S, Chen W, Su Z.
    Int Urol Nephrol; 2017 Jul 01; 49(7):1165-1176. PubMed ID: 28349447
    [Abstract] [Full Text] [Related]

  • 14. Decreased apoptosis repressor with caspase recruitment domain confers resistance to sunitinib in renal cell carcinoma through alternate angiogenesis pathways.
    Gobe GC, Ng KL, Small DM, Vesey DA, Johnson DW, Samaratunga H, Oliver K, Wood S, Barclay JL, Rajandram R, Li L, Morais C.
    Biochem Biophys Res Commun; 2016 Apr 22; 473(1):47-53. PubMed ID: 26995091
    [Abstract] [Full Text] [Related]

  • 15. Relationship between expression of drug-resistance factors and drug sensitivity in normal human renal proximal tubular epithelial cells in comparison with renal cell carcinoma.
    Asakura T, Imai A, Ohkubo-Uraoka N, Kuroda M, Iidaka Y, Uchida K, Shibasaki T, Ohkawa K.
    Oncol Rep; 2005 Sep 22; 14(3):601-7. PubMed ID: 16077962
    [Abstract] [Full Text] [Related]

  • 16. Hypoxia-induced overexpression of stanniocalcin-1 is associated with the metastasis of early stage clear cell renal cell carcinoma.
    Ma X, Gu L, Li H, Gao Y, Li X, Shen D, Gong H, Li S, Niu S, Zhang Y, Fan Y, Huang Q, Lyu X, Zhang X.
    J Transl Med; 2015 Feb 12; 13():56. PubMed ID: 25740019
    [Abstract] [Full Text] [Related]

  • 17. NOTCH1 functions as an oncogene by regulating the PTEN/PI3K/AKT pathway in clear cell renal cell carcinoma.
    Liu S, Ma X, Ai Q, Huang Q, Shi T, Zhu M, Wang B, Zhang X.
    Urol Oncol; 2013 Aug 12; 31(6):938-48. PubMed ID: 21993533
    [Abstract] [Full Text] [Related]

  • 18. RhoB Acts as a Tumor Suppressor That Inhibits Malignancy of Clear Cell Renal Cell Carcinoma.
    Chen W, Niu S, Ma X, Zhang P, Gao Y, Fan Y, Pang H, Gong H, Shen D, Gu L, Zhang Y, Zhang X.
    PLoS One; 2016 Aug 12; 11(7):e0157599. PubMed ID: 27384222
    [Abstract] [Full Text] [Related]

  • 19. Proteomics identified nuclear N-myc downstream-regulated gene 1 as a prognostic tissue biomarker candidate in renal cell carcinoma.
    Hosoya N, Sakumoto M, Nakamura Y, Narisawa T, Bilim V, Motoyama T, Tomita Y, Kondo T.
    Biochim Biophys Acta; 2013 Dec 12; 1834(12):2630-9. PubMed ID: 23999030
    [Abstract] [Full Text] [Related]

  • 20. Downregulation of CLDN7 due to promoter hypermethylation is associated with human clear cell renal cell carcinoma progression and poor prognosis.
    Li Y, Gong Y, Ning X, Peng D, Liu L, He S, Gong K, Zhang C, Li X, Zhou L.
    J Exp Clin Cancer Res; 2018 Nov 14; 37(1):276. PubMed ID: 30428910
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.